Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024
Operating activities
Net increase/(decrease) in net assets resulting from operations	$ 146	$ 146
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on derivatives	0	0
Net change in unrealized gain (loss) on investments	(30)	(30)
Net change in unrealized gain (loss) on derivatives	70	70
Payments to purchase investments		(48,317)
Changes in operating assets and liabilities:
(Increase)/decrease in deferred offering expenses		(1,679)
(Increase)/decrease in due from Operating Manager		(2,005)
Increase in interest receivable		(183)
Increase in prepaid expenses and other assets		(480)
Increase in payable for investments purchased		3,714
Increase in due to Operating Manager		2,382
Increase/(decrease) in offering expenses payable		556
Increase/(decrease) in organizational expenses payable		57
Increase in other accrued expenses and liabilities		827
Net cash used in operating activities		(44,942)
Financing activities
Notes Borrowings		1,072
Proceeds from issuance of shares, net of change in capital subscriptions receivable		50,000
Net cash provided by financing activities		51,072
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents		6,130
Cash and cash equivalents at beginning of period		2
Cash and cash equivalents at end of period	6,132	6,132
Series I
Operating activities
Net increase/(decrease) in net assets resulting from operations	0	0
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on derivatives	0	0
Net change in unrealized gain (loss) on investments	0	0
Net change in unrealized gain (loss) on derivatives	0	0
Payments to purchase investments		0
Changes in operating assets and liabilities:
(Increase)/decrease in deferred offering expenses		675
(Increase)/decrease in due from Operating Manager		314
Increase in interest receivable		0
Increase in prepaid expenses and other assets		(117)
Increase in payable for investments purchased		0
Increase in due to Operating Manager		0
Increase/(decrease) in offering expenses payable		(675)
Increase/(decrease) in organizational expenses payable		(314)
Increase in other accrued expenses and liabilities		0
Net cash used in operating activities		(117)
Financing activities
Notes Borrowings		536
Proceeds from issuance of shares, net of change in capital subscriptions receivable		0
Net cash provided by financing activities		536
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents		419
Cash and cash equivalents at beginning of period		1
Cash and cash equivalents at end of period	420	420
Series II
Operating activities
Net increase/(decrease) in net assets resulting from operations	146	146
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on derivatives	0	0
Net change in unrealized gain (loss) on investments	(30)	(30)
Net change in unrealized gain (loss) on derivatives	70	70
Payments to purchase investments		(48,317)
Changes in operating assets and liabilities:
(Increase)/decrease in deferred offering expenses		(2,354)
(Increase)/decrease in due from Operating Manager		(2,319)
Increase in interest receivable		(183)
Increase in prepaid expenses and other assets		(363)
Increase in payable for investments purchased		3,714
Increase in due to Operating Manager		2,382
Increase/(decrease) in offering expenses payable		1,231
Increase/(decrease) in organizational expenses payable		371
Increase in other accrued expenses and liabilities		827
Net cash used in operating activities		(44,825)
Financing activities
Notes Borrowings		536
Proceeds from issuance of shares, net of change in capital subscriptions receivable		50,000
Net cash provided by financing activities		50,536
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents		5,711
Cash and cash equivalents at beginning of period		1
Cash and cash equivalents at end of period	$ 5,712	$ 5,712